Novartis Expands Cancer Drug Production in the US
Novartis, a Swiss pharmaceutical giant, has just opened a new manufacturing plant in Carlsbad, California. This facility is part of a bigger plan to invest $23 billion in the United States over the next five years. The focus of this new plant is on making cancer drugs, specifically for a treatment called radioligand therapy (RLT). RLT is a type of precision medicine ...